Key points are not available for this paper at this time.
As a useful model in cancer research, zebrafish (Danio rerio) have made substantial contributions to precision medicine, drug testing, and discovery. They are the perfect system for in vivo research of cancer progression and therapy responses because of their fast growth, genetic resemblance to humans, and transparent embryos. This article examines the use of zebrafish in pharmacogenomics, personalised medicine development, and high-throughput cancer medication screening. We also go over the benefits and drawbacks of using zebrafish models in oncological research as well as its possible applications in precision medicine in the future.
Rutuja et al. (Sun,) studied this question.